![ESMO - Eur. Oncology(@myESMO) 's Twitter Profileg](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
ESMO - Eur. Oncology
@myESMO
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
ID:69232855
http://www.esmo.org 27-08-2009 07:45:16
17,6K Tweets
76,0K Followers
884 Following
Follow People
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
📣 Listen to international experts treating real-world cases and get real insights based on the #ESMOGuidelines applicable to your daily practice.
Access with your ESMO account: 🔗ow.ly/B5zQ50S3LON
Nadia Harbeck,MD PhD Rodrigo Sánchez-Bayona Alessandra Gennari MD PhD Andri Papakonstantinou
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-05-31 08:14:10 📣 Listen to international experts treating real-world cases and get real insights based on the #ESMOGuidelines applicable to your daily practice. Access with your ESMO account: 🔗ow.ly/B5zQ50S3LON @Prof_Nadia_H @Rodrosb @ALEDIGNUS12 @AndriPapakonst 📣 Listen to international experts treating real-world cases and get real insights based on the #ESMOGuidelines applicable to your daily practice. Access with your ESMO account: 🔗ow.ly/B5zQ50S3LON @Prof_Nadia_H @Rodrosb @ALEDIGNUS12 @AndriPapakonst](https://pbs.twimg.com/media/GO5KaAaWIAAqYsh.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
👉 View the resources for this thought-provoking discussion of three recent, important publications on #breastcancer #NSCLC and urothelial #cancer .
Access now with your ESMO membership: 🔗ow.ly/6QLm50RYHsQ
Evandro de Azambuja, MD, PhD Benjamin Besse Patrizia Giannatempo
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-05-29 10:30:15 👉 View the resources for this thought-provoking discussion of three recent, important publications on #breastcancer #NSCLC and urothelial #cancer. Access now with your ESMO membership: 🔗ow.ly/6QLm50RYHsQ @E_de_Azambuja @BenjaminBesseMD @giannatempopatr 👉 View the resources for this thought-provoking discussion of three recent, important publications on #breastcancer #NSCLC and urothelial #cancer. Access now with your ESMO membership: 🔗ow.ly/6QLm50RYHsQ @E_de_Azambuja @BenjaminBesseMD @giannatempopatr](https://pbs.twimg.com/media/GOvWYBvXMAAb-2q.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
📣 Call for abstracts: Connect with top oncologists, researchers, and industry leaders at #ESMOASIA24 .
Explore groundbreaking cancer research and innovative treatments. Don't miss the chance to play an active role in it.
Submission deadline: 16 July: ow.ly/qmMI50RWGcu
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-05-29 08:01:11 📣 Call for abstracts: Connect with top oncologists, researchers, and industry leaders at #ESMOASIA24. Explore groundbreaking cancer research and innovative treatments. Don't miss the chance to play an active role in it. Submission deadline: 16 July: ow.ly/qmMI50RWGcu 📣 Call for abstracts: Connect with top oncologists, researchers, and industry leaders at #ESMOASIA24. Explore groundbreaking cancer research and innovative treatments. Don't miss the chance to play an active role in it. Submission deadline: 16 July: ow.ly/qmMI50RWGcu](https://pbs.twimg.com/media/GOu0QfFXwAAQdIJ.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
#ESMOMembers 📢 Voting for the ESMO Presidency 2027-2028 is now open. Learn more about the candidates, Giuseppe Curigliano and Nadia Harbeck, and their vision for the Society. Cast your vote now.
👉ow.ly/fHX850RWt5T
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-05-28 12:02:13 #ESMOMembers 📢 Voting for the ESMO Presidency 2027-2028 is now open. Learn more about the candidates, Giuseppe Curigliano and Nadia Harbeck, and their vision for the Society. Cast your vote now. 👉ow.ly/fHX850RWt5T #ESMOMembers 📢 Voting for the ESMO Presidency 2027-2028 is now open. Learn more about the candidates, Giuseppe Curigliano and Nadia Harbeck, and their vision for the Society. Cast your vote now. 👉ow.ly/fHX850RWt5T](https://pbs.twimg.com/media/GOqh1Y6XwAER-um.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
ESMO has just released recommendations for the use of next-generation sequencing (NGS) for patients with #AdvancedCancer which represent an expansion of the ones published in 2020. Read #ESMODailyReporter to learn more
📌ow.ly/XuNf50RXIKS
![Lung Cancer Europe(@LungCancerEu) 's Twitter Profile Photo Lung Cancer Europe(@LungCancerEu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1581934425960587265/CwvqmTmE_200x200.jpg)
Today is the last day to apply for the European Society for Medical Oncology travel grants to support patient advocates attending the #ESMOCongress 2024 Patient Advocacy Track in #Barcelona from September 13th to 17th, 2024.
More information here: esmo.org/meeting-calend…
![Lung Cancer Europe (@LungCancerEu) on Twitter photo 2024-05-27 05:21:46 Today is the last day to apply for the European Society for Medical Oncology travel grants to support patient advocates attending the #ESMOCongress 2024 Patient Advocacy Track in #Barcelona from September 13th to 17th, 2024. More information here: esmo.org/meeting-calend… Today is the last day to apply for the European Society for Medical Oncology travel grants to support patient advocates attending the #ESMOCongress 2024 Patient Advocacy Track in #Barcelona from September 13th to 17th, 2024. More information here: esmo.org/meeting-calend…](https://pbs.twimg.com/media/GOj8hK4XYAAP8Dn.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
‘Best way to share knowledge in a rapidly-evolving field’, ‘Useful to improve patient care’, ‘Accurate & concise information’: @martatapia1, Javier Cortes MD PhD, Laura Moliner & P. Rutkowski,on why they contribute to and/or read #ESMOBooks 🔗ow.ly/CJzk50RU63l
Ivana Božović
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
There is still time to join this expert exchange and share knowledge with the experts in metastatic #breastcancer .
Register now and join the conversation: 🔗ow.ly/bcZJ50RIwVU
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-05-24 12:01:21 There is still time to join this expert exchange and share knowledge with the experts in metastatic #breastcancer. Register now and join the conversation: 🔗ow.ly/bcZJ50RIwVU There is still time to join this expert exchange and share knowledge with the experts in metastatic #breastcancer. Register now and join the conversation: 🔗ow.ly/bcZJ50RIwVU](https://pbs.twimg.com/media/GOV7RlsXQAA-xXO.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
![Matteo Lambertini, MD PhD(@matteolambe) 's Twitter Profile Photo Matteo Lambertini, MD PhD(@matteolambe) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1036191326558199808/9ywaThpv_200x200.jpg)
Super #ESMOYOC meeting to plan future exciting activities for ESMO - Eur. Oncology young members: so privileged to work with such brilliant minds ❤️Maria Kfoury Pablo Mando Rille Rodrigo Sánchez-Bayona Elene Mariamidze Myrto K. Moutafi Liz Connolly Pawel Sobczuk Hongcheng Zhu 祝鸿程 Deniz Can Guven Emre Kocakavuk, MD, PhD
![Matteo Lambertini, MD PhD (@matteolambe) on Twitter photo 2024-05-22 18:38:26 Super #ESMOYOC meeting to plan future exciting activities for @myESMO young members: so privileged to work with such brilliant minds ❤️@kfoury_maria @PabloMando @rillepihlak @Rodrosb @EMariamidze @mkmoutafi @DrLizConnolly @pawel_sobczuk @DrHongchengZhu @DenizCanGuven1 @ekocakavuk Super #ESMOYOC meeting to plan future exciting activities for @myESMO young members: so privileged to work with such brilliant minds ❤️@kfoury_maria @PabloMando @rillepihlak @Rodrosb @EMariamidze @mkmoutafi @DrLizConnolly @pawel_sobczuk @DrHongchengZhu @DenizCanGuven1 @ekocakavuk](https://pbs.twimg.com/media/GONC-mpWcAAa4z3.jpg)
![Pablo Mando(@PabloMando) 's Twitter Profile Photo Pablo Mando(@PabloMando) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1322256102717874176/j5SolE5E_200x200.jpg)
Some of the many highlights of #ESMOBreast24
🗝️DOLAF trial and its interesting hypothesis of combining PARPi and ET and IO
🗝️ T-DXd retreatment safety after G1 ILD
🗝️ Growth in data of fertility related topics in young BRCA patients
🗝️ Sexual health in the center of the stage
![Kevin Punie(@kevinpunie) 's Twitter Profile Photo Kevin Punie(@kevinpunie) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1226438732565434368/FGT1eucF_200x200.jpg)
#ESMOBreast24 #ESMOAmbassadors
🔑🚫Primary outcome in IMpassion132 highlights unmet need for early relapsing #TNBC
🔑Emerging data from ADC-IO combinations
🔑Safety and #QoL updates for new 💊capivasertib and 💉datopotamab
🔑📈Body of evidence for new biomarkers 🎯such as HER2Dx
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
![Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1454840948349939718/N7-QBrt1_200x200.jpg)
Early recurrent TNBC represents a major unmet need in breast oncology, with unfortunately no added benefit from PD-L1 inhibition added to chemotherapy.
Novel ADCs are being evaluated in this population, with great hopes for improved outcomes.
#ESMOBreast24 #ESMOAmbassadors
![Matteo Lambertini, MD PhD(@matteolambe) 's Twitter Profile Photo Matteo Lambertini, MD PhD(@matteolambe) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1036191326558199808/9ywaThpv_200x200.jpg)
Important data at #ESMOBreast14 in #survivorship field including safety of vaginal estrogen therapy for selected patients, physical exercise in advanced disease and fertility techniques in #BRCA carriers (personal COI here)…what a fantastic event!!!
ESMO - Eur. Oncology #ESMOAmbassadors
![Ben Westphalen(@BenWestphalen) 's Twitter Profile Photo Ben Westphalen(@BenWestphalen) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1407571807675113472/3cxt9_Xw_200x200.png)
![Ben Westphalen(@BenWestphalen) 's Twitter Profile Photo Ben Westphalen(@BenWestphalen) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1407571807675113472/3cxt9_Xw_200x200.png)
This is going to be fun🤩
✅Two very interesting cases
🚀Two bright young colleagues presenting
and Myrto K. Moutafi running the show…what can go wrong?
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
Do not miss the chance to attend the upcoming YO4YO Clinical Case Discussion where Ben Westphalen, Myrto K. Moutafi, Erman Akkus and Paolo D’arienzo will discuss how to approach a genomic profiling report for choosing the next line of therapy.
📌ow.ly/BoLO50RP7H1
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-05-22 12:02:15 Do not miss the chance to attend the upcoming YO4YO Clinical Case Discussion where @BenWestphalen, @mkmoutafi, @Erman_Akkus and Paolo D’arienzo will discuss how to approach a genomic profiling report for choosing the next line of therapy. 📌ow.ly/BoLO50RP7H1 Do not miss the chance to attend the upcoming YO4YO Clinical Case Discussion where @BenWestphalen, @mkmoutafi, @Erman_Akkus and Paolo D’arienzo will discuss how to approach a genomic profiling report for choosing the next line of therapy. 📌ow.ly/BoLO50RP7H1](https://pbs.twimg.com/media/GOLoTcWWkAI2AWM.jpg)